The obstetric management of sickle cell diseaseHOWARD, Jo; OTENG-NTIM, Eugene.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2012, Vol 26, Num 1, pp 25-36, issn 1521-6934, 12 p.Article

Human Sickle Cell Blood Modulates Endothelial Heme Oxygenase Activity: Effects on Vascular Adhesion and ReactivityBAINS, Sandip K; FORESTI, Roberta; HOWARD, Jo et al.Arteriosclerosis, thrombosis, and vascular biology. 2010, Vol 30, Num 2, pp 305-312, issn 1079-5642, 8 p.Article

Cannabis use in sickle cell disease : a questionnaire studyHOWARD, Jo; ANIE, Kofi A; HOLDCROFT, Anita et al.British journal of haematology. 2005, Vol 131, Num 1, pp 123-128, issn 0007-1048, 6 p.Article

The presence of α-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell diseaseVASAVDA, Nisha; BADIGER, Sheela; REES, David et al.British journal of haematology. 2008, Vol 143, Num 4, pp 589-592, issn 0007-1048, 4 p.Article

Effects of co-existing α-thalassaemia in sickle cell disease on hydroxycarbamide therapy and circulating nucleic acidsVASAVDA, Nisha; WOODLEY, Claire; ALLMAN, Marlene et al.British journal of haematology. 2012, Vol 157, Num 2, pp 249-252, issn 0007-1048, 4 p.Article

The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trialHOWARD, Jo; MALFROY, Moira; FIJNVANDRAAT, Karin et al.Lancet (British edition). 2013, Vol 381, Num 9870, pp 930-938, issn 0140-6736, 9 p.Article

Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell diseaseHULBERT, Monica L; MCKINSTRY, Robert C; HOWARD, Jo et al.Blood. 2011, Vol 117, Num 3, pp 772-779, issn 0006-4971, 8 p.Article